Treatment with low doses of GI254023X causes a mild decrease in ADAM10 surface expression that correlates with a marked impairment of HCV infectivity. by Belén Carriquí-Madroñal (17396512)

Structure of YOLOv5s-SBC. by Zhongjian Xie (4633099)

“…Compared to the original model, P-YOLOv5s-GRNF decreased parameters by 18%, decreased model size to 11.9MB, decreased FLOPs to 14.5G, and increased FPS by 4.3. …”

S100A7 downregulation decreases the phosphorylation of EGFR/HER2, Src and SHP2 in MDA-MB-468 cell lines. by Vikram Paruchuri (87721)

RavZ_LLO decreases the association of polyubiquitinated species with the LCV harboring <i>L</i>. <i>longbeachae</i>. by Yunjia Shi (14593468)

Does Mean Platelet Volume Decrease in the presence of Coronary Artery Fistula? by Isa Sincer (7234577)

LiCl and MTR decrease polyQ toxicity measuring ASH neuronal death in the absence of growth. by Cindy Voisine (30589)

Decrease of body, thymus and adrenal weight after MD. by Nienke A. V. Derks (3207168)

<b> </b> Rate of brain weight to body weight in different experimental groups. AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. Each value represents mean ± SEM, n = 6, **p < 0.01 vs. saline group and ⁺⁺p < 0.01 vs. Alcl3 group. <i>Abbreviation</i>s: Sal, Saline; Exo [2], Two injections of exosomes; Exo [5], five injections of exosomes. by Atefeh Sadeghi (21253051)

“…AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. …”

Proposed model of S100A8/9 induction. by Mohamad Karaky (8910497)

Subjects:

Decrease in <i>Sox2</i> expression results in similar phenotypes as disruptions to FGFR1 signaling. by Lu M. Yang (6919364)

Effect of perfusion with VEGF121 on outflow facility. by Tomokazu Fujimoto (709192)

Non-hydrolysable ATP analogues prevent decrease of I_Ca,L by metabolic inhibition. by Giedrius Kanaporis (4405525)

Stx16 depletion leads to decrease in E-cadherin levels and formation of multiple lumens in epithelial cysts. by Jae-Joon Jung (139625)

Overexpression of human PGRN mRNA prevents the decrease in axon outgrowth produced by knockdown of zebrafish PGRN. by Angela S. Laird (360986)

“…<p>A) The decreased axonal length produced by knockdown of <i>grna</i> with a 5′UTR MO was rescued by co-expression of PGRN mRNA. * significantly different from grna CO MO, p<0.02; ̂ significantly different from <i>grna</i> MO + GFP, p<0.0001. …”

ALDH2 inhibitors decrease stroma-induced ALDH activity in AML cells and sensitize them to chemotherapy. by Bin Yuan (19897)

Blocking the interaction between S100A9 protein and RAGE V domain using S100A12 protein - Fig 4 by Revansiddha Katte (5394665)

“…<p>(A). Emission spectra of 2 μM S100A9 fluorescence titrations exhibiting decreased fluorescence intensities with increasing concentration of S100A12 at the micromolar level. …”

Long-lasting sparks promoted by decreasing RyR open probability in a ventricular myocyte model. by Zhen Song (412533)

Mutation of Ser-489 in GC-B to alanine but not glutamate decreases CNP-stimulated guanylyl cyclase activity. by Andrea R. Yoder (165684)

Demethylation of HPV16 LCR CpG sites decreases E6 and E7 expression. by Chunlin Zhang (663063)

“…<p>Demethylation of the CpG sites induced by 0.5 μM 5-aza-dc for 96 h decreased E6 and E7 expression, which was detected by reverse transcription PCR <b>A)</b> and quantitative real-time PCR <b>B)</b>; E6 and E7 were clearly decreased in UM-SCC47 and CaSki cells, but there was no obvious change in SiHa cells. …”

<i>In vitro</i> treatment with the broad spectrum caspase inhibitor Q-VD-OPh reduces the number of active caspase-3-positive cells in parallel with a decrease in the entry of micro... by María Martín-Estebané (623506)